Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

5 Stocks That Are Getting Battered and Bruised Today

At a time when crude futures are in the green and the major indexes are flat, shares of five stocks, Catabasis Pharmaceuticals Inc (NASDAQ:CATB), Flexion Therapeutics Inc (NASDAQ:FLXN), DryShips Inc. (NASDAQ:DRYS), Sunoco LP (NYSE:SUN), and Fibrocell Science Inc (NASDAQ:FCSC) are sharply down today. Let’s find out why traders are selling off these equities and see how the smart money is positioned in them.

At Insider Monkey, we track around 765 hedge funds and institutional investors. Through extensive backtests, we have determined that imitating some of the stocks that these investors are collectively bullish on, can help retail investors generate double digits of alpha per year. The key is to focus on the small-cap picks of these funds, which are usually less followed by the broader market and allow for larger price inefficiencies (see the details here).

weerasak saeku/

weerasak saeku/

Catabasis Pharmaceuticals Retreats on Clinical Results

Catabasis Pharmaceuticals Inc (NASDAQ:CATB) is 26% lower today after a Phase 2a trial showed that the company’s drug candidate CAT-2054 failed to achieve the study’s primary endpoint of statistically lowering bad cholesterol compared to a placebo. Non-HDL and triglyceride did not change statistically either. Catabasis will stop investing in CAT-2054 for the treatment of hypercholesterolemia as a result. The company will continue to focus on CAT-2054 for the indication of non-alcoholic steatohepatitis, however. Three funds that we track owned 10.7% of Catabasis Pharmaceuticals Inc (NASDAQ:CATB)’s shares at the end of March, out of 766 funds in Insider Monkey’s database.

Follow Catabasis Pharmaceuticals Inc (NASDAQ:CATB)
Trade (NASDAQ:CATB) Now!

Flexion Raises Money

Flexion Therapeutics Inc (NASDAQ:FLXN) shares have retreated by 11% after the company announced that it will start a $60 million public offering of stock. The underwriters have a 30-day option to buy another $9 million of additional shares. Wells Fargo, RBC, and BMO are the joint book runners. The exact pricing of the offering hasn’t been released yet. Ten funds in our system were long Flexion Therapeutics Inc (NASDAQ:FLXN) at the end of the first quarter.

Follow Flexion Therapeutics Inc (NASDAQ:FLXN)
Trade (NASDAQ:FLXN) Now!

On the next page we examine why shares of DryShips Inc, Sunoco LP, and Fibrocell Science Inc are sinking today.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.